Patients with Prostate, Other Urological Cancers Are 5 Times More Likely to Commit Suicide, UK Study Shows

Patients with Prostate, Other Urological Cancers Are 5 Times More Likely to Commit Suicide, UK Study Shows
The suicide rate in patients with urological cancers — such as prostate, kidney or bladder cancer — is five times higher than in people without cancer, results from a large U.K. survey show. Data also demonstrated that the proportion of completed suicide attempts is higher in cancer patients, especially in those with urological cancers. The research, “Patients with urological malignancy are 5 times more likely to commit suicide: A large national cohort study,” highlights the need for improved assessment and treatment of mental health needs in cancer care, the authors said. Their work was presented at the 2018 Annual European Association of Urology (EAU) Congress, held in Copenhagen, Denmark. The scientists conducted the largest U.K. study addressing suicide in patients with cancer. It was also the first analysis of suicidal intent in cancer patients, defined as the proportion of suicides to attempted suicides. Prior research found that depression affects between 5% and 25% of cancer patients, while a 2014 series of studies from Scotland showed that most cancer patients diagnosed with depression were not receiving treatment. The latest study examined 2001-11 records from England and Wales. From a total of 980,761 patients (493,234 men, 487,094 women), researchers identified 162 suicides and 1,222 suicide attempts. Results showed that the
Subscribe or to access all post and page content.

Tagged , , , , , .

José is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.

One comment

  1. metastatic says:

    Prostate Cancer Staging and Survival Rate Staging
    On: March 30, 2018

    Prostate Cancer Staging and Survival Rate Staging is a standard method to decide the seriousness of the tumor. Metastatic prostate disease survival rate would then be able to be evaluated after the malignancy organize has been found. Prostate Cancer Staging The arranging framework for prostate growth depends on American Joint Committee on Cancer (AJCC) TNM framework. TNM itself remains for Tumor, Node and Metastasis. Metastatic prostate disease survival rate in each patient can be extraordinary and the TNM framework is the initial step to make sense of the patient’s guess. There are five imperative things TNM framework can tell. The T class will tell about the degree of the tumor while the N classification is utilized to tell whether the growth has influenced encompassing lymph hubs or not. In the interim, the M will tell regardless of whether the growth has metastasized to different organs. Furthermore, the framework likewise will give data about the patient’s PSA level and the probability for the disease to spread in light of the Gleason score. In the wake of gathering those five data

Leave a Comment

Your email address will not be published. Required fields are marked *